SK Bioscience Co Ltd

Common Name
SK Bioscience
Country
South Korea
Sector
Healthcare
Industry
Biotechnology
Employees
917
Ticker
302440
Exchange
KOREA EXCHANGE
Description
Sk Bioscience Co., Ltd. is a South Korean biopharmaceutical company that specializes in the development, manufacturing, and distribution of vaccines. As a key player in the healthcare sector, the comp...

SK Bioscience's GHG Emissions Data Preview

In 2023, SK Bioscience completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

However, SK Bioscience has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data

Verified Sources Behind SK Bioscience’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore SK Bioscience’s data sources below and access millions more through our Disclosure Search.

a. SK Bioscience's ESG Data Spreadsheet 2024
a. SK Bioscience's ESG Data Spreadsheet 2024
b. SK Bioscience's Sustainability Report 2022
b. SK Bioscience's Sustainability Report 2022

Insights into SK Bioscience's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of SK Bioscience amounted to 19,616 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of SK Bioscience increased by 6.07%, suggesting that the company faced challenges in reducing its emissions from its core operations. a

SK Bioscience's Scope 1 Emissions Over Time

2019202020212022202301.5 k3 k4.5 k6 ktCO2e+10%+21%+6%+13%
  • Total Scope 1
  • Year-over-Year Change

What are SK Bioscience's Scope 1 emissions?

In 2023, the total Scope 1 emissions of SK Bioscience were 5,863 metric tons of CO₂ equivalent (tCO₂e). a

Has SK Bioscience reduced its Scope 1 emissions over time?

Since 2019, SK Bioscience's Scope 1 emissions have increased by 60.15%, reflecting a rising long-term trend in Scope 1 emissions over time. a b

Compared to the previous year (2022), SK Bioscience's Scope 1 emissions increased by 13.34%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a

What are SK Bioscience's Scope 2 emissions?

In 2023, SK Bioscience reported Scope 2 greenhouse gas (GHG) emissions of 13,753 tCO₂e without specifying the calculation method. a

Has SK Bioscience reduced its Scope 2 emissions over time?

Since 2019, SK Bioscience's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have increased by 52.54%, reflecting a rising long-term trend in Scope 2 emissions over time. a b

Compared to the previous year (2022), SK Bioscience's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that SK Bioscience 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does SK Bioscience use for Scope 2 reporting?

In 2023, SK Bioscience reported its Scope 2 emissions using an unspecified methodology. a

SK Bioscience's Scope 2 Emissions Over Time

2019202020212022202303.5 k7 k10.5 k14 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into SK Bioscience's Value Chain Emissions

In 2023, SK Bioscience reported 116,063 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a

The 2023 disclosure of SK Bioscience includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2022, demonstrating consistent Scope 3 emissions reporting coverage year over year. a

SK Bioscience's Scope 3 Emissions Over Time

202120222023040 k80 k120 k160 ktCO2e-35%+17%
  • Total Scope 3
  • Year-over-Year Change

What are SK Bioscience's Scope 3 emissions?

In 2023, SK Bioscience reported total Scope 3 emissions of 116,063 metric tons of CO₂ equivalent (tCO₂e). a

Compared to the previous year (2022), SK Bioscience's Scope 3 emissions increased by 16.87%, suggesting that the company faced challenges in reducing emissions across its value chain. a

Insights into SK Bioscience’s GHG Emissions Intensity Compared to Industry Peers

In 2023, SK Bioscience reported Scope 1 greenhouse gas (GHG) emissions of 5,863 tCO₂e and total revenues of USD 289 millions. This translates into an emissions intensity of 20.28 tCO₂e per millions USD. a

SK Bioscience's Scope 1 Emissions Intensity Compared to Peers

0.51020010,000200,000Scope 1 Emissions (tCO2e)10502001,00010,000Revenues (Millions of USD)BALSInnoCare PharmaYear: 2023Scope 1: 20 tCO2eRevenue: $M 104Scope 1 Intensity: 0.19 tCO2e/$MPharma MarYear: 2023Scope 1: 1,233 tCO2eRevenue: $M 175Scope 1 Intensity: 7.04 tCO2e/$MRemeGenYear: 2024Scope 1: 54 tCO2eRevenue: $M 234Scope 1 Intensity: 0.23 tCO2e/$MBBBlue Jet HealthcareYear: 2025Scope 1: 23,877 tCO2eRevenue: $M 120Scope 1 Intensity: 198.82 tCO2e/$MIdorsiaYear: 2024Scope 1: 733 tCO2eRevenue: $M 124Scope 1 Intensity: 5.90 tCO2e/$MInsmedYear: 2024Scope 1: 1,666 tCO2eRevenue: $M 364Scope 1 Intensity: 4.58 tCO2e/$MBB BiotechYear: 2024Scope 1: 12 tCO2eRevenue: $M 91Scope 1 Intensity: 0.13 tCO2e/$MShanghai Junshi BiosciencesYear: 2024Scope 1: 5,308 tCO2eRevenue: $M 267Scope 1 Intensity: 19.88 tCO2e/$MEverest MedicinesYear: 2023Scope 1: 0 tCO2eRevenue: $M 19Scope 1 Intensity: 0.02 tCO2e/$MFrontage HoldingsYear: 2023Scope 1: 2,883 tCO2eRevenue: $M 2,027Scope 1 Intensity: 1.42 tCO2e/$MAkesoYear: 2024Scope 1: 6,408 tCO2eRevenue: $M 318Scope 1 Intensity: 20.17 tCO2e/$MSK BiopharmaceuticalsYear: 2024Scope 1: 414 tCO2eRevenue: $M 373Scope 1 Intensity: 1.11 tCO2e/$MAAAurisco PharmaceuticalYear: 2024Scope 1: 2,731 tCO2eRevenue: $M 202Scope 1 Intensity: 13.51 tCO2e/$MLLLigaChem BiosciencesYear: 2023Scope 1: 308 tCO2eRevenue: $M 27Scope 1 Intensity: 11.53 tCO2e/$MHLBYear: 2024Scope 1: 131 tCO2eRevenue: $M 46Scope 1 Intensity: 2.82 tCO2e/$MSSSichuan Kelun-Biotech BiopharmaceuticalYear: 2023Scope 1: 6,335 tCO2eRevenue: $M 237Scope 1 Intensity: 26.78 tCO2e/$MSamsung BiologicsYear: 2023Scope 1: 69,262 tCO2eRevenue: $M 2,891Scope 1 Intensity: 23.96 tCO2e/$MCelltrionYear: 2024Scope 1: 27,147 tCO2eRevenue: $M 2,424Scope 1 Intensity: 11.20 tCO2e/$MVIVA Biotech HoldingsYear: 2022Scope 1: 1,404 tCO2eRevenue: $M 373Scope 1 Intensity: 3.76 tCO2e/$MBiontechYear: 2024Scope 1: 2,405 tCO2eRevenue: $M 3,341Scope 1 Intensity: 0.72 tCO2e/$MCamurusYear: 2024Scope 1: 116 tCO2eRevenue: $M 169Scope 1 Intensity: 0.68 tCO2e/$MCytokineticsYear: 2024Scope 1: 242 tCO2eRevenue: $M 18Scope 1 Intensity: 13.10 tCO2e/$MAlnylam PharmaceuticalsYear: 2024Scope 1: 3,832 tCO2eRevenue: $M 2,248Scope 1 Intensity: 1.70 tCO2e/$MSK BioscienceYear: 2023Scope 1: 5,863 tCO2eRevenue: $M 289Scope 1 Intensity: 20.28 tCO2e/$M

How does SK Bioscience's GHG emissions intensity compare to its peers?

In 2023, SK Bioscience reported a Scope 1 emissions intensity of 20.28 tCO₂e per millions USD. Compared to the peer group median of 4.58 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a

Where does SK Bioscience rank on GHG emissions intensity within its industry?

In 2023, SK Bioscience ranked 21 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places SK Bioscience among the least efficient performers, with one of the highest emissions intensities in its sector. a

Insights into SK Bioscience's Total Carbon Footprint

In 2023, SK Bioscience reported a total carbon footprint of 135,679 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 15.18% increase compared to 2022, suggesting a rise in emissions across its operations or value chain. a

The largest contributor to SK Bioscience's total carbon footprint was Scope 3 emissions, accounting for 85.54% of the company's total carbon footprint, followed by Scope 2 emissions at 10.14%. a

Want Full Access to SK Bioscience's GHG Emissions Dataset?
Sign Up